Clinical trials
Thrombosis, Venous clinical trials
Below are recruiting thrombosis, venous clinical trials, each written for real people, not researchers. We’re tracking 66 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07814118Enrolling by invitation
Understanding how your body works during routine care
This study looks at how different body systems work together in people with various conditions and healthy volunteers. It uses routine medical tests and data to understand health better, which can help improve future care.
New York, New YorkAges 18 years+ - NCT05021198Recruiting
Study for people diagnosed with cerebral venous thrombosis
This study is for people who have been diagnosed with cerebral venous thrombosis (a blood clot in the brain’s venous system) at specific hospitals. It looks back at cases from 2014 to 2023 to learn from real-world patients.
LørenskogAges Any age - NCT07801638Recruiting
Anticoagulation plus tocilizumab for cerebral venous thrombosis
This trial tests a combination of blood thinners (anticoagulation) and a drug called tocilizumab, which targets inflammation, to treat acute cerebral venous thrombosis (a blood clot in a vein in the brain). It aims to see if this combined treatment improves recovery and reduces complications compared to blood thinners alone.
Beijing, Beijing MunicipalityAges 18–80 - NCT04660747Recruiting
Anticoagulant medication choices for cerebral venous thrombosis
This study looks at people with cerebral venous thrombosis who were treated with blood thinners taken by mouth (or started within the first 30 days). It uses observational data to understand how these treatments are used and what outcomes may follow.
Amsterdam, North HollandAges 18 years+ - NCT07352358RecruitingPhase 4
Blood thinners plus batroxobin for brain vein clots
This trial tests whether adding a medication called batroxobin to standard blood thinners can help treat blood clots in the veins of the brain better than blood thinners alone. It is for people who have been diagnosed in the last month and are not at high risk for bleeding.
Beijing, Beijing MunicipalityAges 18–80 - NCT06551402RecruitingPhase 3
Dabigatran vs rivaroxaban for cerebral venous thrombosis
This study compares two blood thinners (dabigatran and rivaroxaban) to see which works better for treating a blood clot in the brain's veins. You may be eligible if you have a new diagnosis of this type of stroke and can start treatment within 14 days.
Kafr ash ShaykhAges 18–75 - NCT05701917Recruiting
Clot-busting device versus blood thinners for leg clot
This study compares a clot-removal device (ClotTriever) plus standard care versus standard blood thinners alone for a deep vein clot in the leg. It aims to see which approach better improves leg symptoms and outcomes.
Scottsdale, ArizonaAges 18 years+ - NCT07210671Recruiting
Study on treating vein clots in cancer patients
This study looks at how to best treat blood clots in veins near the skin in people who also have active cancer. It will compare different treatment options to find what works best and is safest for you.
AmiensAges 18 years+ - NCT07083609Recruiting
Blood-thinning pills for cerebral vein blood clots
This trial tests whether taking blood-thinning pills (called DOACs) after initial treatment can safely treat blood clots in the veins of the brain. You may be able to join if you recently had this condition and start the pills within the first two weeks of treatment.
Hanoi, HanoiAges 18 years+ - NCT06672250Recruiting
Tumor cells and blood clots in veins
This study looks at the link between tumor cells found in the blood and blood clots in the veins. It is for people who have had or will have a procedure to remove a blood clot, whether they have cancer or not.
New Taipei CityAges 18–80 - NCT03881345Recruiting
Registry for blood clots in legs or lungs
This registry collects information from people who have a blood clot in a leg or a clot in the lung. It helps researchers understand how these conditions are treated in real life.
Moscow, MoscowAges 18 years+ - NCT03919305Recruiting
Study of blood clots in brain veins
This study follows people who have a blood clot in the brain’s venous drainage system. It aims to better understand this condition and may help improve how it is recognized and managed.
BeijingAges Any age - NCT06650826Recruiting
Antibodies and blood clots in young adults
This study looks for certain antibodies in the blood of people aged 18 to 60 who have had a blood clot without a clear cause, or soon after an infection or vaccine, or who have had clots return despite treatment. It aims to understand why these clots happen.
BerlinAges 18–60 - NCT06947707Recruiting
Blood thinners for brain blood clot in Chinese patients
This trial tests two blood thinner medicines, edoxaban and rivaroxaban, in Chinese patients with a blood clot in a brain vein (cerebral venous thrombosis). It aims to see if these medicines are safe and work well.
Beijing, Beijing MunicipalityAges 18–80 - NCT02650453Recruiting
Registry for surgeries to restore blocked deep leg veins
This study keeps a registry (a secure list of patient information) for people who have major blockages in deep veins in the leg or pelvis and need a vein repair procedure. It may help doctors understand outcomes over time and improve future care.
MaastrichtAges Any age - NCT06472518RecruitingPhase 4
Clot-busting treatment plus blood thinners for severe leg clots
This trial tests whether combining a clot-busting procedure (pharmaco-mechanical thrombolysis) with standard blood thinners works better than blood thinners alone for people with severe, recently formed deep vein clots in the upper leg.
NantesAges 18 years+ - NCT07399977Recruiting
Blood test to guide blood thinner use in cancer
This study tests whether a blood test and computer program can help doctors decide how long you need to take blood thinners after a cancer-related blood clot. If you've been on a blood thinner for a few months and have certain cancers, this trial may offer a more personalized approach.
Basking Ridge, New JerseyAges 18 years+ - NCT05711173Recruiting
Study blood clot triggers and immune cell changes in clot patients
This study looks at how certain blood cell changes and immune system activity may relate to blood clots in specific veins or lungs. It may help researchers understand why clots happen “without a clear cause” and how to better predict risk.
BordeauxAges 6–50 - NCT04211181Recruiting
Prevent blood clots in hospitalized teens and adults
This study looks at a prevention plan to reduce the risk of hospital-acquired blood clots. It may help people who are expected to stay in the hospital for several days but do not already have a clot.
Beijing, Beijing MunicipalityAges 14 years+ - NCT06417541Recruiting
Study of blood clots from central lines using CT scans
This study uses special CT scans (photon-counting CT) to look for blood clots related to central lines, both in patients who have passed away and in living patients. It aims to better understand and detect these clots.
Lund, Skåne CountyAges 18 years+ - NCT07622212Recruiting
Comparing devices to clear leg blood clots quickly
This trial compares different mechanical devices used to remove recent blood clots from the deep veins in your leg (iliac and femoral veins). The goal is to restore blood flow and prevent long-term complications like chronic pain and swelling.
ShanghaiAges 18–85 - NCT06124768Recruiting
Comparing two blood clot removal methods for leg clots
This trial compares two ways of doing a mechanical blood clot removal procedure for people with a new deep vein thrombosis (a blood clot in a deep vein, often in the leg). The goal is to see which method works better.
Shanghai, Shanghai MunicipalityAges 18–85 - NCT07196020Recruiting
Predicting blood clots during chemotherapy for certain cancers
This study looks at whether doctors can predict blood clots in people with certain cancers who are receiving chemotherapy. If you have ovarian, lung, stomach, or pancreatic cancer and are starting chemotherapy, you may be able to join and help improve clot prevention.
Cork, IrelandAges 18 years+ - NCT06288906Recruiting
Mechanical Clot Removal for Deep Vein Thrombosis
This trial tests a mechanical device that removes blood clots from deep veins in the pelvis or leg. It may be an option if you have a large clot and are at low risk for bleeding.
Milan, ItalyAges 18 years+
Hear when a new Thrombosis, Venous trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for thrombosis, venous?
- Yes. Clin2 currently lists 66 recruiting thrombosis, venous studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a thrombosis, venous trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a thrombosis, venous trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.